Case-control exploration of relationships between early rash or liver toxicity and plasma concentrations of nevirapine and primary metabolites. [electronic resource]
- HIV clinical trials
- 391-9 p. digital
Publication Type: Journal Article
1528-4336
10.1310/hct0806-391 doi
Case-Control Studies Exanthema--chemically induced Female HIV Protease Inhibitors--adverse effects Humans Liver--drug effects Liver Function Tests Male Nevirapine--adverse effects Plasma--chemistry